STAT3/miR-15a-5p/CX3CL1 Loop Regulates Proliferation and Migration of Vascular Endothelial Cells in Atherosclerosis

Hui Li1, Hui-Min Zhang2, Li-Juan Fan3

  • 1College of Life Sciences and Health, School of Resource and Environmental Engineering, Wuhan University of Science and Technology, Hubei, 430081, P.R.China.

Insights

MicroRNA-15a-5p (miR-15a-5p) targets STAT3 signaling to regulate vascular endothelial cell proliferation, offering a potential therapeutic strategy for coronary atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Atherosclerosis Research

Background:

  • Vascular injury-induced endothelial cell proliferation contributes to atherosclerosis, the basis of coronary heart disease.
  • The specific roles of Signal Transducer and Activator of Transcription 3 (STAT3) in microRNA regulation and endothelial dysfunction within atherosclerosis remain largely undefined.

Purpose of the Study:

  • To elucidate the regulatory mechanism of STAT3 and microRNA-15a-5p (miR-15a-5p) in endothelial cell proliferation and their implications in atherosclerosis.

Main Methods:

  • Investigated the interplay between STAT3, Interleukin-6 (IL-6), CX3CL1, and miR-15a-5p in endothelial cells.
  • Assessed the impact of STAT3 activation and miR-15a-5p modulation on vascular endothelial cell proliferation and CX3CL1 expression.

Main Results:

  • STAT3 activation by IL-6 upregulates CX3CL1 expression.
  • miR-15a-5p inhibits both vascular endothelial cell proliferation and STAT3-mediated CX3CL1 transcription.
  • A feedback loop exists where STAT3 positively regulates CX3CL1, which is then inhibited by miR-15a-5p, controlling endothelial cell proliferation.

Conclusions:

  • miR-15a-5p plays a critical role in regulating endothelial cell proliferation by modulating the STAT3/CX3CL1 pathway.
  • miR-15a-5p represents a promising therapeutic target for managing coronary atherosclerosis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.3K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
371